| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.15 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |